Amgen and AstraZeneca share positive results in chronic rhinosinusitisnews2024-11-08T19:30:06+00:00November 8th, 2024|Endpoints News|
Eisai slashes Leqembi sales forecast by almost $100Mnews2024-11-08T18:37:28+00:00November 8th, 2024|Endpoints News|
Pfizer to invest $1B in China over next five years — reportsnews2024-11-07T20:13:39+00:00November 7th, 2024|Endpoints News|
Vaccine makers face headwinds from RFK, soft demand and Chinanews2024-11-07T18:25:57+00:00November 7th, 2024|Endpoints News|
FDA seeks to pull OTC nasal decongestant ingredient due to lack of efficacynews2024-11-07T17:02:53+00:00November 7th, 2024|Endpoints News|
Genmab chops early cancer prospects to prioritize Phase 3 projectsnews2024-11-07T16:21:56+00:00November 7th, 2024|Endpoints News|
Gilead beats Covid drug sales forecasts, takes $1.75B hit on Trodelvy study failnews2024-11-07T12:27:53+00:00November 7th, 2024|Endpoints News|
Moderna reports $10M in first RSV sales, a slow start for new vaccinenews2024-11-07T11:30:04+00:00November 7th, 2024|Endpoints News|
California voters say yes to restrictions around 340B spendingnews2024-11-06T19:58:47+00:00November 6th, 2024|Endpoints News|
